Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation. (2017)

First Author: Manook M

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/ajt.14234

PubMed Identifier: 28226413

Publication URI: http://europepmc.org/abstract/MED/28226413

Type: Journal Article/Review

Volume: 17

Parent Publication: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Issue: 8

ISSN: 1600-6135